Weekly News Round-Up – 3/4/20

With the coronavirus showing no sign of letting up for the next few months at least, we won’t either, bringing you the most up-to-date news on efforts to combat Covid-19 from around the world. This week: Gilead begins remdesivir trials...

5 days ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-Up – 3/4/20

With the coronavirus showing no sign of letting up for the next few months at least, we won’t either, bringing you the most up-to-date news on efforts to combat Covid-19 from around the world. This week: Gilead begins remdesivir trials...

5 days ago

Weekly News Round-up – 27/3/20

It’s that time again! We’ve got all the news you wanted this week, as long as you wanted to read about nothing except COVID-19, constantly. But to cheer things up, we’ve left out the story that we’re heading towards a...

2 weeks ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 27/3/20

It’s that time again! We’ve got all the news you wanted this week, as long as you wanted to read about nothing except COVID-19, constantly. But to cheer things up, we’ve left out the story that we’re heading towards a...

2 weeks ago

How Close are We to a COVID-19 Treatment?

Despite the warnings of SARS, MERS, swine and bird flu, the coronavirus COVID-19 took the entire world by surprise. Governments, health workers and pharmaceutical executives were unprepared for the rapid spread of the pandemic across the globe. Now they are...

2 weeks ago
R&D,Clinical Development,Clinical Operations,News

How Close are We to a COVID-19 Treatment?

Despite the warnings of SARS, MERS, swine and bird flu, the coronavirus COVID-19 took the entire world by surprise. Governments, health workers and pharmaceutical executives were unprepared for the rapid spread of the pandemic across the globe. Now they are...

2 weeks ago

Weekly News Round-up – 20/3/20

For those of you who’ve lost track of the days in this WFH nightmare, it’s Friday again! Seeing as any pretence of not talking about coronavirus is entirely gone, welcome to: The Round-up Coronavirus Special (Part 1 of 12) UK’S...

3 weeks ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 20/3/20

For those of you who’ve lost track of the days in this WFH nightmare, it’s Friday again! Seeing as any pretence of not talking about coronavirus is entirely gone, welcome to: The Round-up Coronavirus Special (Part 1 of 12) UK’S...

3 weeks ago

Weekly News Round-Up – 6/3/20

Pharma weekly news A bit of a break from the big C-word this week, with news on three major mergers that have, like buses, all turned up at once: the Abbvie/Allergan merger has been cleared by the EU, with a...

1 month ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-Up – 6/3/20

Pharma weekly news A bit of a break from the big C-word this week, with news on three major mergers that have, like buses, all turned up at once: the Abbvie/Allergan merger has been cleared by the EU, with a...

1 month ago

Weekly News Round-up – 28/2/20

Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...

1 month ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 28/2/20

Covid-19 continues to dominate the news, with pharma companies racing to find the cure. Moderna and Gilead look currently set to lead, with vaccines from both now entering human trials. In other news, Novartis' Beovu, which appeared in last week's...

1 month ago

What’s the Future of Patient Centricity?

Clinical trials rely fundamentally on patient engagement. While these trials can often prove life-saving, patient recruitment and retention has long been an issue for researchers. Simply increasing the amount of patients in a study means delays, increased costs, and patients...

1 month ago
Clinical Development,Clinical Operations,News

What’s the Future of Patient Centricity?

Clinical trials rely fundamentally on patient engagement. While these trials can often prove life-saving, patient recruitment and retention has long been an issue for researchers. Simply increasing the amount of patients in a study means delays, increased costs, and patients...

1 month ago

Weekly News Round-up – 21/2/20

Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...

2 months ago
R&D,Bioprocess,Clinical Development,Weekly Roundups

Weekly News Round-up – 21/2/20

Fascinating news this week as scientists at MIT found the first strong antibiotics devised entirely by machine learning algorithm. The resulting medicines have so far proven highly effective against ‘critical’ pathogens. The scientists are now intending to search for more...

2 months ago

Clinical Operations: Biggest Challenges Facing the Industry in 2020

I’m often asked, by clients across the globe, what the main Clinical Operations challenges facing pharma and biotech companies really are. Where are they investing their resources? What takes up their time? Where are their efforts going to be focused...

2 months ago
Clinical Development,Clinical Operations,News

Clinical Operations: Biggest Challenges Facing the Industry in 2020

I’m often asked, by clients across the globe, what the main Clinical Operations challenges facing pharma and biotech companies really are. Where are they investing their resources? What takes up their time? Where are their efforts going to be focused...

2 months ago

Weekly News Round-up – 14/2/20

The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...

2 months ago
Oncology,Bioprocess,Clinical Development,Weekly Roundups,Biology

Weekly News Round-up – 14/2/20

The U.S. Institute for Clinical and Economic Review’s (ICER’s) methods could see legal challenges in the near future, a think tank has warned, due to discrimination against disabled individuals. In other news, Novartis’ rare lung cancer drug capmatinib will be...

2 months ago